Page Contents
An asset is considered impaired when its carrying amount exceeds its recoverable amount. In such cases, the entity must recognize an impairment loss in its financial statements.
The standard defines:
Ind AS 36 requires entities to assess at each reporting date whether indicators of impairment exist.
External Indicators
Some important external indicators include Significant decline in market value, Adverse technological or economic changes, an increase in market interest rates and Market capitalization lower than net assets
Internal Indicators
Internal indicators may include obsolescence or physical damage, poor operating performance, idle assets or restructuring plans, and negative internal cash flow trends. Notably, goodwill and indefinite-life intangible assets must be tested annually, irrespective of impairment indicators.
This represents the price obtainable from selling the asset in an orderly transaction between market participants, less disposal costs.
Valuation Approaches under Ind AS 113 : Entities may apply Market Approach, Cost Approach and Income Approach. The selection depends on asset nature and data availability.
Value in Use is the present value of future cash flows expected from the continuing use of an asset or Cash-Generating Unit (CGU). The VIU model typically involves Forecasting future cash inflows, estimating operating outflows, determining terminal value and applying an appropriate discount rate. This is often the more complex and judgment-intensive area of impairment testing.
Future Cash Flow Projections: Ind AS 36 prescribes specific principles regarding cash flow estimates.
Cash Flows to Include Entities should include cash inflows from continuing use, necessary operating outflows, disposal proceeds at end of useful life and maintenance capital expenditures.
Cash Flows to Exclude: The following are specifically prohibited: future uncommitted restructurings, financing cash flows, Income tax cash flows and Future enhancement expenditures unless already committed. Cash flow projections should generally be based on approved budgets for a maximum period of five years unless a longer period can be justified.
Discount Rate – The Core Valuation Judgment The selection of a discount rate significantly impacts impairment valuation. Ind AS 36 requires use of a:
Entities commonly use Weighted Average Cost of Capital (WACC), CAPM methodology and Incremental borrowing rates and The discount rate must Reflect market participant assumptions, avoid double-counting risks and remain independent of financing structure
Cash-Generating Units (CGUs)
Often, individual assets do not generate independent cash flows. In such cases, impairment testing is performed at the CGU level. A CGU is “the smallest identifiable group of assets generating largely independent cash inflows.” Determining CGUs requires considerable judgment and depends on internal management monitoring, operational structure, and independent revenue generation patterns.
The carrying amount of a CGU should comprise only those assets that Directly belong to the CGU, or Can be allocated to the CGU on a reasonable and consistent basis, and Contribute to generating the future cash flows considered in the Value in Use (VIU) calculation. Liabilities are generally not included in the CGU carrying amount unless the recoverable amount cannot be determined without considering those liabilities.
| Item | Include in CGU? |
| Plant & Machinery | Yes |
| Working Capital Assets | Yes (where relevant) |
| Allocable Corporate Assets | Yes |
| Goodwill Allocated to CGU | Yes |
| Deferred Tax Assets | No |
| General Borrowings | No |
| Pension Obligation | Depending on valuation approach |
| Decommissioning Liability | Generally, no; include only when assumed by buyer |
| Income Tax Liability | No |
The most common error in impairment testing includes entity-level items such as deferred tax assets, corporate liabilities, and financing liabilities within the CGU carrying amount. Under Ind AS 36, only those assets and liabilities that are directly linked to the CGU’s cash flows should be considered, ensuring consistency between the carrying amount and the recoverable amount
Goodwill arising from business combinations must be allocated to CGUs expected to benefit from acquisition synergies. Key principles include Mandatory annual impairment testing, testing at the lowest monitored level, and no reversal of goodwill impairment permitted under Ind AS 36. This prohibition distinguishes Ind AS 36 from earlier Indian GAAP practices.
Recognition and Allocation of Impairment Loss
When impairment arises at the CGU level, goodwill is reduced first, and the remaining loss is allocated proportionately among CGU assets. However, asset values cannot be reduced below: Fair value less costs of disposal, value in use and zero. This ensures impairment allocation remains commercially reasonable.
Reversal of Impairment
Ind AS 36 permits reversal of impairment losses for assets other than goodwill if assumptions underlying prior impairment have changed. However, Reversal is capped at original carrying amount adjusted for depreciation and Goodwill impairment reversal is strictly prohibited
Disclosure Requirements
Ind AS 36 contains extensive disclosure obligations aimed at enhancing transparency. Entities must disclose Amount of impairment losses/reversals, events triggering impairment, key assumptions used, discount rates applied, growth assumptions, and sensitivity analysis for key CGUs. Disclosure quality is increasingly becoming a focus area for auditors and regulators alike.
| Parameter | FVLCOD | VIU |
| Basis | Market participant view | Entity-specific view |
| Valuation Objective | Sale value | Value from continued use |
| Future Restructuring | May be included | Excluded unless committed |
| Future Enhancements | May be included | Excluded until incurred |
| Discount Rate | Market participant rate | Pre-tax asset-specific rate |
| Synergies | Limited to market participant synergies | Entity-specific synergies allowed |
| Primary Standard Reference | Ind AS 113 + Ind AS 36 | Ind AS 36 |
In real-life impairment engagements:
Ind AS 36 is largely converged with IAS 36; however, some differences exist due to Indian accounting and regulatory requirements.
| S. No. | Difference | Explanation |
| 1 | Investment Property | Paragraph 2(f) of IAS 36 has been omitted in Ind AS 36 because Ind AS 40 does not permit the fair value model in the same manner as IAS 40 and generally requires the cost model. |
| 2 | Transitional Provisions | IAS 36 contains its own transition requirements. Ind AS 36 excludes these because transition matters are covered comprehensively by Ind AS 101 (First-time Adoption of Indian Accounting Standards). |
| 3 | Terminology Changes | Ind AS uses Indian Companies Act terminology such as: “Balance Sheet” instead of “Statement of Financial Position” and “Statement of Profit and Loss” instead of “Statement of Comprehensive Income”. These are drafting changes and do not affect accounting treatment. |
| 4 | Impact of Ind AS 113 | Certain paragraphs of IAS 36 (Para 25-27 and 5(b)) have been deleted because the guidance relating to fair value is now covered by Ind AS 113 (Fair Value Measurement). |
| 5 | Numbering Consistency | Paragraphs 91-95 remain numbered in Ind AS 36 even though they are deleted, to maintain consistency with IAS 36 numbering. |
| 6 | Illustrative Examples | Certain IAS 36 illustrative examples that do not form part of the standard have not been incorporated into Ind AS 36. |
Practical Conclusion: Ind AS 36 vs IAS 36 : From an impairment testing perspective, recognition of impairment, recoverable amount determination, value in use method, goodwill testing, and CGU concepts are substantially identical between IAS 36 and Ind AS 36. Most differences are drafting, transitional, and fair-value-presentation related.
The differences between Ind AS 36 and the erstwhile Indian GAAP standard AS 28 are much more significant.
| S. No. | Ind AS 36 | AS 28 |
| 1 | Applies to investments in subsidiaries, associates and joint ventures in separate financial statements. | Does not apply to these investments. |
| 2 | Specifically excludes biological assets, employee benefit assets, assets held for sale, etc. | No similar comprehensive exclusions. |
| 3 | Mandatory annual impairment testing for goodwill, indefinite-life intangibles, and intangibles not yet available for use. | Annual testing not mandatory unless indicators exist. |
| 4 | Goodwill impairment reversal is prohibited under all circumstances. | Reversal may be permitted in limited exceptional circumstances. |
| 5 | Goodwill allocated to CGUs benefiting from acquisition synergies. | Uses bottom-up and top-down approaches for goodwill allocation. |
| 6 | Uses “Fair Value Less Costs of Disposal”. | Uses “Net Selling Value”. |
| 7 | Extensive disclosure requirements including sensitivity analysis and goodwill disclosures | Comparatively limited disclosures. |
Quick Revision
| Particulars | IAS 36 | Ind AS 36 | AS 28 |
| Annual Goodwill Test | Yes | Yes | No |
| Goodwill Reversal | No | No | Allowed in limited cases |
| FVLCOD Concept | Yes | Yes | No |
| Investments in Subsidiaries Covered | Yes | Yes | No |
| Extensive Disclosure | Yes | Yes | Limited |
| Based on CGU Concept | Yes | Yes | Limited application |
For professionals working under Ind AS, the most important operational changes from AS 28 are Mandatory annual impairment testing of goodwill, No reversal of goodwill impairment, Use of Fair Value Less Costs of Disposal instead of Net Selling Value, Greater reliance on valuation techniques (DCF, market approach, fair value hierarchy) and much more extensive disclosure and documentation requirements. These changes make Ind AS 36 substantially closer to global IFRS practices under IAS 36.
Some common practical difficulties faced by companies include Determining reliable cash flow forecasts, Selection of suitable peer-based discount rates, Identifying appropriate CGUs, evaluating long-term growth assumptions, Performing sensitivity analysis and assessing impairment during economic uncertainty. Accordingly, impairment testing frequently requires collaboration between Finance teams, Valuation specialists, auditors, and Strategic management
Impairment testing under Ind AS 36 is far more than an accounting formality. It is an integrated valuation exercise combining finance, economics, forecasting, and strategic assessment. Robust impairment analysis helps organizations improve governance, enhance reporting credibility, align asset values with economic realities, and build investor trust.
As businesses continue to face rapid market changes, geopolitical uncertainties, and technological disruptions, effective impairment testing will remain one of the most critical aspects of financial reporting and valuation practice. For professional assistance in impairment valuation, CGU assessment, WACC determination, financial modeling, and Ind AS advisory, connect with Rajput Jain & Associates.
Compliance Calendar for the Month of July 2026 The Compliance Calendar for July 2026 covers key statutory due dates under… Read More
GSTN Revises Timeline for Amendment of Aggregate Annual Turnover for FY 2025-26 GSTN through its advisory dated 1 July 2026,… Read More
Institute of Chartered Accountants of India to Help Tirumala Tirupati Devasthanams Enhance Accounting System significant development where Tirumala Tirupati Devasthanams,… Read More
Understanding Clubbing of Income & Tax Logic Behind Gifting Assets Gifting money or assets to family members is a common… Read More
FSSAI Update for Food Businesses: Revised Turnover Thresholds Effective from 01.04.2026 The Food Safety and Standards Authority of India (FSSAI)… Read More
Tax Alert in 15k to 20k cases: The ‘Swapped Provisions’ Trap via attempted to reduce their tax liability The Income… Read More